Related Experiment Videos
Safety aspects of omeprazole
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1986
Abstract:
Omeprazole has been given to more than 2500 subjects, mostly in short-term studies for 2-4 weeks, but also to some patients for more than 2 years. An analysis of side-effects has so far not shown a specific pattern that could be attributed to the drug.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The clinical safety of omeprazole.
Digestion·1990
The clinical safety of omeprazole.
Scandinavian journal of gastroenterology. Supplement·1989
Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study.
Alimentary pharmacology & therapeutics·1988
Gastric emptying and absorption of acetylsalicylic acid administered as enteric-coated micro-granules.
European journal of clinical pharmacology·1982
Iron prophylaxis in menorrhagia.
Acta obstetricia et gynecologica Scandinavica·1981
Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.
Scandinavian journal of gastroenterology. Supplement·2006
Argon plasma coagulation for radiation proctitis.
Scandinavian journal of gastroenterology. Supplement·2006
Endosonography in anorectal disease: an overview.
Scandinavian journal of gastroenterology. Supplement·2006
Chemoprevention for colon cancer: new opportunities, fact or fiction?
Scandinavian journal of gastroenterology. Supplement·2006
Sentinel node staging in colon carcinoma: value of sentinel lymph node biopsy with radiocolloid and blue staining.
Scandinavian journal of gastroenterology. Supplement·2006
Optimizing the detection of hereditary non-polyposis colorectal cancer: an update.
Scandinavian journal of gastroenterology. Supplement·2006
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026